Physician profile

Brian C Griner

Pediatrics · Valdosta, GA

NPI 1366470650

$4,637.34

in general payments reported to CMS, 2019-2025

49 companies · $562 in 2025

The $562 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,168.70

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Pfizer INC. $677.28 2019-2025
Novo Nordisk INC $553.52 2019-2025 Wegovy
Dexcom, INC. $435.92 2021-2025 Dexcom G6 Transmitter
Supernus Pharmaceuticals, INC. $214.88 2023-2024 Qelbree, Qelbree
Corium, LLC $202.27 2021-2023 Azstarys
Astrazeneca Pharmaceuticals LP $191.07 2020-2025 Airsupra, Flumist Quadrivalent, Breztri
Novartis Pharmaceuticals Corporation $171.18 2019-2024
Merck Sharp & Dohme LLC $149.06 2019-2024 Gardasil 9, Vaxneuvance, M-M-R II
Lilly USA, LLC $148.75 2020-2025 Mounjaro, Trulicity, Zepbound
Intuitive Surgical, INC. $132.49 2025
Allergan, INC. $130.83 2020
Sanofi-Aventis U.S. LLC $130.02 2019-2024
Janssen Pharmaceuticals, INC $128.24 2019-2024 Spravato
Abbott Laboratories $115.67 2021-2024 Freestyle Libre 3, Freestyle Libre, Freestyle Libre 2
Abbvie INC. $110.74 2021-2025
Show all 49 companies
CompanyGeneral paymentsYearsTop products
Sanofi Pasteur INC. $104.79 2019-2025
Glaxosmithkline, LLC. $76.36 2021-2023 Arexvy, Shingrix
Takeda Pharmaceuticals U.S.A., INC. $74.65 2019-2021
Amarin Pharma, INC. $71.78 2019-2021
Ironshore Pharmaceuticals INC. $70.61 2019-2023 Jornay Pm
Biohaven Pharmaceuticals, INC. $61.05 2021
Bayer Healthcare Pharmaceuticals INC. $55.57 2022-2025
Horizon Therapeutics Plc $46.75 2020-2021
Portola Pharmaceuticals, LLC $44.39 2019-2020
Idorsia Pharmaceuticals US INC $39.26 2022-2023 Quviviq
Krystal Biotech INC $38.06 2024-2025 Vyjuvek
Exact Sciences Corporation $36.40 2023-2025 The Cologuard Plus Collection Kit, Cologuard Collection Kit
Neurelis, INC. $35.40 2021-2023 Valtoco
Alexion Pharmaceuticals, INC. $30.53 2021
Biohaven Pharmaceutical Holding Company LTD. $30.16 2022
Seqirus USA INC $28.63 2025 Flucelvax, Fluad
Biosense Webster, INC. $27.15 2019
Amgen INC. $23.72 2019-2020
Verrica Pharmaceuticals INC. $23.29 2024 Ycanth
Corcept Therapeutics $20.07 2025 Korlym
Soleno Therapeutics, INC. $18.13 2025 Vykat Xr
Genentech USA, INC. $17.43 2021
Organogenesis INC. $17.31 2025 Affinity
Shield Therapeutics INC $17.15 2024
Boehringer Ingelheim Pharmaceuticals, INC. $15.79 2019
Cranial Technologies, INC $15.47 2022
Axsome Therapeutics, INC. $14.96 2025 Auvelity
Genzyme Corporation $14.23 2023
Neos Therapeutics, LP $14.20 2020
Philips North America LLC $13.94 2023
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $13.15 2024 Xifaxan
Biogen, INC. $11.99 2021
E.R. Squibb & Sons, L.L.C. $11.86 2019
Arbor Pharmaceuticals, INC. $11.19 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Brian C Griner

$4,637.34

in general payments reported 2019-2025

Years
2019-2025
Top company
Pfizer INC.
Context
The $562 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).

https://glasscript.com/doctor/198020/brian-c-griner

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.